Alzheimer’s Disease: Differences of Transdermal versus Oral Treatment on Caregiving Time
Background: Data on indirect effects of dementia treatment on caregiver burden obtained from naturalistic studies are still lacking. We explored differences between patients with oral and transdermal application of acetylcholine esterase inhibitors regarding caregiver’s time burden and psychopatholo...
Main Authors: | O. Riedel, A. Emmrich, J. Klotsche, R. Dodel, H. Förstl, W. Maier, H. Reichmann, H.-U. Wittchen |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-11-01
|
Series: | Dementia and Geriatric Cognitive Disorders Extra |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/342929 |
Similar Items
-
USE OF A RIVASTIGMINE TRANSDERMIC PATCH IN ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE DEMENTIA
by: Lacramioara Perju Dumbrava, et al.
Published: (2009-03-01) -
Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease
by: Davide V Moretti, et al.
Published: (2014-07-01) -
A prospective study on the use of rivastigmine transdermal patch in Alzheimer's dementia in a routine clinical setting
by: Ejaz Nazir, et al. -
Visual Hallucinations Due to Rivastigmine Transdermal Patch Application in Alzheimer's Disease; The First Case Report
by: Yıldız Değirmenci, et al.
Published: (2016-12-01) -
Burden, anxiety and depression in caregivers of Alzheimer patients in the Dominican Republic
by: Martin Medrano, et al.